Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00593944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00612612. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Belimumab in Patients with Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05069051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
ClinicalTrials.gov study NCT06250465. IPD Sharing: NO. Countries: 1. Publications: 0.
The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib
ClinicalTrials.gov study NCT03528941. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.
ClinicalTrials.gov study NCT01762202. IPD Sharing: NO. Countries: 1. Publications: 0.
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION
ClinicalTrials.gov study NCT07313982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03971565. IPD Sharing: NO. Countries: 1. Publications: 0.
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03447808. IPD Sharing: NO. Countries: 1. Publications: 0.
Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05371392. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission
ClinicalTrials.gov study NCT00458523. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02046928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02461316. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01005368. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cy
ClinicalTrials.gov study NCT01416974. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04210219. IPD Sharing: YES. Countries: 7. Publications: 0.
A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT01005979. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05971251. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy
ClinicalTrials.gov study NCT00108108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated
ClinicalTrials.gov study NCT00233506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.